BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18827450)

  • 1. Carcinogenic comparative study on rasH2 mice produced by two breeding facilities.
    Machida K; Urano K; Yoshimura M; Tsutsumi H; Nomura T; Usui T
    J Toxicol Sci; 2008 Oct; 33(4):493-501. PubMed ID: 18827450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interlaboratory comparison of short-term carcinogenicity studies using CB6F1-rasH2 transgenic mice.
    Takaoka M; Sehata S; Maejima T; Imai T; Torii M; Satoh H; Toyosawa K; Tanakamaru ZY; Adachi T; Hisada S; Ueda M; Ogasawara H; Matsumoto M; Kobayashi K; Mutai M; Usui T
    Toxicol Pathol; 2003; 31(2):191-9. PubMed ID: 12696579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of IC tags in short-term carcinogenicity study on CB6F1 TGrasH2 mice.
    Urano K; Suzuki S; Machida K; Sawa N; Eguchi N; Kikuchi K; Fukasawa K; Taguchi F; Usui T
    J Toxicol Sci; 2006 Dec; 31(5):407-18. PubMed ID: 17202757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid induction of more malignant tumors by various genotoxic carcinogens in transgenic mice harboring a human prototype c-Ha-ras gene than in control non-transgenic mice.
    Yamamoto S; Mitsumori K; Kodama Y; Matsunuma N; Manabe S; Okamiya H; Suzuki H; Fukuda T; Sakamaki Y; Sunaga M; Nomura G; Hioki K; Wakana S; Nomura T; Hayashi Y
    Carcinogenesis; 1996 Nov; 17(11):2455-61. PubMed ID: 8968063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examination of percutaneous application in a 26-week carcinogenicity test in CB6F1-TG rasH2 mice.
    Urano K; Suzuki S; Machida K; Eguchi N; Sawa N; Kikuchi K; Hattori Y; Usui T
    J Toxicol Sci; 2007 Oct; 32(4):367-75. PubMed ID: 17965551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twenty-six-Week carcinogenicity study of chloroform in CB6F1 rasH2-transgenic mice.
    Sehata S; Maejima T; Watanabe M; Ogata S; Makino T; Tanaka K; Manabe S; Takaoka M
    Toxicol Pathol; 2002; 30(3):328-38. PubMed ID: 12051550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twenty-six-week carcinogenicity study of sulfamethoxazole in CB6F1-Tg-rasH2 mice.
    Torii M; Itoh F; Yabuuchi K; Ohno K; Kominami G; Hirano K; Tasaki T; Nara H
    J Toxicol Sci; 2001 May; 26(2):61-73. PubMed ID: 11429969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Methyl-N-Nitrosourea (MNU): A positive control chemical for p53+/- mouse carcinogenicity studies.
    Morton D; Bailey KL; Stout CL; Weaver RJ; White KA; Lorenzen MJ; Ball DJ
    Toxicol Pathol; 2008 Dec; 36(7):926-31. PubMed ID: 18827072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological features of spontaneous and induced tumors in transgenic mice carrying a human prototype c-Ha-ras gene used for six-month carcinogenicity studies.
    Mitsumori K; Koizumi H; Nomura T; Yamamoto S
    Toxicol Pathol; 1998; 26(4):520-31. PubMed ID: 9715511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. rasH2 mouse: reproducibility and stability of carcinogenicity due to a standardized production and monitoring system.
    Tsutsumi H; Inoue R; Yasuda M; Takahashi R; Suzuki M; Urano K
    J Toxicol Pathol; 2022 Jan; 35(1):19-24. PubMed ID: 35221492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty-six-week oral carcinogenicity study of 3-monochloropropane-1,2-diol in CB6F1-rasH2 transgenic mice.
    Lee BS; Park SJ; Kim YB; Han JS; Jeong EJ; Son HY; Moon KS
    Arch Toxicol; 2017 Jan; 91(1):453-464. PubMed ID: 27017489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tg.rasH2 Mice and not CByB6F1 Mice Should Be Used for 28-Day Dose Range Finding Studies Prior to 26-Week Tg.rasH2 Carcinogenicity Studies.
    Paranjpe MG; Belich J; Vidmar TJ; Elbekai RH; McKeon M; Brown C
    Int J Toxicol; 2017; 36(4):287-292. PubMed ID: 28553733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicology and carcinogenesis studies of acrylonitrile (CAS No. 107-13-1) in B6C3F1 mice (gavage studies).
    Natl Toxicol Program Tech Rep Ser; 2001 Oct; (506):1-201. PubMed ID: 11803701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicology and carcinogenesis studies of pyrogallol (CAS No. 87-66-1) in F344/N rats and B6C3F1/N mice (dermal studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2013 Feb; (574):1-167. PubMed ID: 23518671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Tg rasH2 mouse in cancer hazard identification.
    Morton D; Alden CL; Roth AJ; Usui T
    Toxicol Pathol; 2002; 30(1):139-46. PubMed ID: 11890467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 26-Week carcinogenicity study of di-isodecyl phthalate by dietary administration to CB6F1-rasH2 transgenic mice.
    Cho WS; Jeong J; Choi M; Park SN; Han BS; Son WC
    Arch Toxicol; 2011 Jan; 85(1):59-66. PubMed ID: 20358181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicology and carcinogenesis studies of isoeugenol (CAS No. 97-54-1) in F344/N rats and B6C3F1 mice (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2010 Sep; (551):1-178. PubMed ID: 21372857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP technical report on the toxicology and carcinogenesis studies of Elmiron (Cas No. 37319-17-8) in F344/N rats and B6C3F1 mice (Gavage Studies).
    National Toxicology Program, Public Health Services, National Institutes of Health, US Department of Health and Human Services,
    Natl Toxicol Program Tech Rep Ser; 2004 May; (512):7-289. PubMed ID: 15213766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinogenicity and organ specificity of N-trimethylsilylmethyl-N-nitrosourea (TMS-MNU), N-neopentyl-N-nitrosourea (neoPNU), and N-methyl-N-nitrosourea (MNU) in rats.
    Maekawa A; Onodera H; Kanno J; Furuta K; Nagaoka T; Todate A; Matsushima Y; Oh-hara T; Kawazoe Y
    J Cancer Res Clin Oncol; 1988; 114(5):473-6. PubMed ID: 3182906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.